Home
Conditions
Mantle Cell Lymphoma

Clinical trial condition

Mantle Cell Lymphoma

Explore clinical trials studying Mantle Cell Lymphoma. Study availability and eligibility vary by location and protocol.

251 public trials 59 recruiting studies

Refine in advanced search Browse all conditions

Mantle Cell Lymphoma trial results

Recruiting

Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment

NCT06784167

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +33 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Recruiting

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

NCT06340737

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +38 more
Locations: Stanford University Palo Alto, California, United States

View Trial Details

Recruiting

Zanubrutinib Plus Rituximab for Patients With Indolent Mantle Cell Lymphoma

NCT05635162

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Royal Derby Hospital Derby, United Kingdom

Beatson West of Scotland Cancer Centre Glasgow, United Kingdom

Clatterbridge Cancer Centre Liverpool, United Kingdom

Guy's Hospital London, United Kingdom

View all 13 locations

View Trial Details

Recruiting

Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

NCT05281809

Conditions: B Acute Lymphoblastic Leukemia, B-cell Lymphoma, Burkitt Lymphoma, +36 more
Locations: AHN Cancer Institute - West Penn Hospital Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell Lymphoma

NCT06341556

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy

NCT05255354

Conditions: Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +13 more
Locations: Stanford Cancer Center Palo Alto, California, United States

View Trial Details

Recruiting

CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma

NCT06482684

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: University Hospital of Mainz Mainz, Germany

Klinikum der Universität München Munich, Germany

View Trial Details

Recruiting

Italian Observational Study on CAR-T Therapy for Lymphoma

NCT06339255

Conditions: Diffuse Low Grade B-Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +12 more
Locations: Fondazione IRCCS Istituto Nazionale Tumori Milan, Italy

View Trial Details

Recruiting

A Phase 2 Trial of GlOfitamab anD pIrtobrutinib in Mantle Cell Lymphoma Patients With Prior BTK Inhibitor Exposure.

NCT05833763

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Peter MacCallum Cancer Centre Parkville, Victoria, Australia

Sir Charles Gairdener Nedlands, Western Australia, Australia

View Trial Details

Enrolling by Invitation

CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas

NCT07168486

Conditions: B-cell Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +31 more
Locations: University of Maryland, Baltimore Baltimore, Maryland, United States

View Trial Details

Mantle Cell Lymphoma

Mantle Cell Lymphoma trial results

Related conditions